Chemoinformaics analysis of DIHYDROXYACIDISSIMINOL
| Molecular Weight | 427.541 | nRot | 11 |
| Heavy Atom Molecular Weight | 394.277 | nRig | 14 |
| Exact Molecular Weight | 427.236 | nRing | 2 |
| Solubility: LogS | -3.431 | nHRing | 0 |
| Solubility: LogP | 2.638 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 68.8642 |
| nHD | 4 | BPOL | 36.2798 |
| QED | 0.413 |
| Synth | 3.214 |
| Natural Product Likeliness | 0.475 |
| NR-PPAR-gamma | 0.035 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.366 |
| Pgp-sub | 0.643 |
| HIA | 0.632 |
| CACO-2 | -4.913 |
| MDCK | 0.0000239 |
| BBB | 0.538 |
| PPB | 0.951863 |
| VDSS | 1.42 |
| FU | 0.0149419 |
| CYP1A2-inh | 0.219 |
| CYP1A2-sub | 0.046 |
| CYP2c19-inh | 0.309 |
| CYP2c19-sub | 0.293 |
| CYP2c9-inh | 0.513 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.249 |
| CYP2d6-sub | 0.63 |
| CYP3a4-inh | 0.082 |
| CYP3a4-sub | 0.431 |
| CL | 9.858 |
| T12 | 0.458 |
| hERG | 0.137 |
| Ames | 0.014 |
| ROA | 0.022 |
| SkinSen | 0.155 |
| Carcinogencity | 0.101 |
| EI | 0.011 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.372 |
| Antiviral | Yes |
| Prediction | 0.571623 |